Treatment duration of brigatinib in patients enrolled in the international expanded access program (EAP)

被引：0
|
作者：
Lin, M. M. [1 ]
Pan, X. [1 ]
Hou, P. [1 ]
Allen, S. [1 ]
Baumann, P. [1 ]
Hochmair, M. J. [2 ,3 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Otto Wagner Spital, Dept Resp & Crit Care Med, Vienna, Austria
[3] Otto Wagner Spital, Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108O
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [11] EXPANDED-ACCESS PROGRAM (EAP) OF SUNITINIB IN 458 PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Sternberg, C. N.
    Porta, C.
    Bracarda, S.
    Carteni, G.
    Lo Re, G.
    Ruggeri, E. M.
    Conte, P.
    Monfardini, S.
    Gasparini, G.
    Ciuffreda, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 194 - 194
  • [12] EXPANDED ACCESS PROGRAM (EAP) FOR LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Palumbo, A.
    Gay, F.
    Buda, G.
    Guglielmelli, T.
    Perrone, G.
    Corradini, P.
    Benedetti, F.
    Offidani, M.
    Rossi, D.
    Gozzetti, A.
    Catalano, L.
    Canepa, L.
    Di Raimondo, F.
    Patriarca, F.
    Petrucci, M. T.
    Di Renzo, N.
    Galli, M.
    Cavallo, F.
    Bringhen, S.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 257 - 257
  • [13] Pembrolizumab expanded access program (EAP) in Spain: clinical activity.
    Arance, Ana
    Piulats, Josep M.
    Rodas, Ivan Marquez
    Manzano, Jose Luis
    Berrocal, Alfonso
    Algarra, Salvador Martin
    Crespo, Guillermo
    Rodriguez, Delvys
    Guerrero, Miguel Angel Berciano
    Soria, Ainara
    Ruiz, Elisabeth Perez
    Castano, Almudena Garcia
    Montagut, Clara
    Puertolas, Teresa
    Aguado, Carlos
    Royo, Maria Angeles
    Blanco, Remei
    Munoz-Couselo, Eva
    Sanchis, Pilar Mut
    Gonzalez-Cao, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [14] Treatment beyond progression in patients with advanced RCC participating in the expanded access programme (EAP)
    Cortesi, E.
    Cappuzzo, F.
    Galli, L.
    Bearz, A.
    Pignata, S.
    Berruti, A.
    Tortora, G.
    Tassinari, D.
    Panni, S.
    Pazzola, A.
    Surico, G.
    Maio, M.
    Latini, L.
    Schinzari, G.
    Adamo, V.
    Ricevuto, E.
    Cognetti, F.
    De Giorgi, U.
    Carteni, G.
    Basso, U.
    ANNALS OF ONCOLOGY, 2017, 28
  • [15] Baseline Characteristics of Patients With Fabry Disease Enrolled in the Pegunigalsidase Alfa Expanded-Access Program
    Mehta, Ankit
    Wilcox, William
    Nedd, Khan J.
    Bernat, John A.
    Knoll, Jasmine
    Jefferies, John L.
    Longo, Nicola
    Wallace, Eric L.
    Almon, Einat
    Alon, Sari
    Chertkoff, Raul
    Sullivan, Dawn
    Rocco, Rossana
    Koulinska, Irene
    Goker-Alpan, Ozlem
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 417 - 417
  • [16] Pemetrexed alone or in combination with cisplatin in the treatment of patients with peritoneal mesothelioma (PM): Outcomes of an expanded access program (EAP) in patients with malignant mesothelioma (MM).
    Bloss, J
    Wozniak, A
    Janne, P
    Belani, C
    Keohan, M
    Ross, H
    Polikoff, J
    Mintzer, D
    Bloss, L
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 665S - 665S
  • [17] Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
    Del Vecchio, M.
    Di Giacomo, A. M.
    Quaglino, P.
    Sileni, V. Chiarion
    Queirolo, P.
    De Galitiis, F.
    Cognetti, F.
    Mandala', M.
    Guidoboni, M.
    Rinaldi, G.
    Depenni, R.
    Consoli, F.
    Troiani, T.
    Guida, M.
    Marconcini, R.
    Ferrucci, P. F.
    Bersanelli, M.
    Rossi, E.
    Aglietta, M.
    Ascierto, P. A.
    ANNALS OF ONCOLOGY, 2021, 32 : S890 - S891
  • [18] Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)
    Yerton, Megan
    Winter, Allison
    Gelevski, Dario
    Addy, Grace
    Kostov, Anthony
    Lieberman, Cassandra
    Weber, Harli
    Doyle, Michael
    Kane, Geli
    Cohen, Caroline
    Parikh, Neil
    Burke, Katherine M.
    Rohrer, Margot
    Stirrat, Taylor
    Bruno, Margaret
    Hochman, Alison
    Luppino, Sarah
    Scalia, Jennifer
    D'Agostino, Derek
    Sinani, Ervin
    Yu, Hong
    Drake, Kristin
    Hagar, Jennifer
    Sherman, Alexander V.
    Babu, Suma
    Berry, James D.
    Cudkowicz, Merit E.
    Paganoni, Sabrina
    MUSCLE & NERVE, 2023, 67 (06) : 456 - 463
  • [19] A single-institution experience with the pembrolizumab (PEM) Expanded Access Program (EAP)
    Perdon, Karen Mae
    Kim, Dae Won
    Balmes, Gener C.
    VanAnh Trinh
    McIntyre, Susan E.
    Diab, Adi
    Amaria, Rodabe Navroze
    Patel, Sapna Pradyuman
    Hwu, Patrick
    James, Marihella
    Philip, Ann
    Vardeleon, Anna
    Cain, Suzanne
    Hwu, Wen-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [20] Safety and efficacy of ABT 378/r in the German expanded access program (EAP)
    Voigt, E
    Wasmuth, JC
    Braitinger, D
    Kupfer, B
    Kaiser, R
    Rockstroh, JK
    AIDS, 2000, 14 : S29 - S30
12345